|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 720.00 INR | +0.33% |
|
-0.44% | +2.53% |
| Market Cap | 7.32B 76.67M 66.6M 61.85M 57.04M 107M 109M 732M 287M 3.64B 288M 282M 12.23B | P/E 2024 |
45.4x | P/E 2025 | 45.4x |
|---|---|---|---|---|---|
| Enterprise Value | 7.28B 76.23M 66.21M 61.48M 56.7M 107M 109M 728M 285M 3.61B 286M 280M 12.15B | EV / Sales 2024 |
4.69x | EV / Sales 2025 | 2.12x |
| Free-Float |
24.75% | Yield 2024 |
0.09% | Yield 2025 | 0.07% |
| 1 day | +0.33% | ||
| 1 week | -0.44% | ||
| Current month | -7.60% | ||
| 1 month | -7.60% | ||
| 3 months | +5.06% | ||
| 6 months | +11.46% | ||
| Current year | +2.53% |
| 1 week | 705 | 730 | |
| 1 month | 705 | 810.05 | |
| Current year | 580 | 937 | |
| 1 year | 580 | 952 | |
| 3 years | 501.25 | 1,417.38 | |
| 5 years | 213.91 | 1,417.38 | |
| 10 years | 213.91 | 1,417.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 38 | 2023-01-15 | |
Bhavik Shah
DFI | Director of Finance/CFO | - | 2026-07-08 |
| Compliance Officer | - | 2023-01-05 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 38 | 2015-09-20 | |
| Chairman | 41 | 2015-09-20 | |
| Director/Board Member | 38 | 2015-09-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.33% | -0.44% | -22.44% | +36.45% | 87.63M | ||
| -2.02% | -6.06% | +51.81% | +147.17% | 1,030B | ||
| -0.13% | -3.27% | +54.66% | +52.09% | 617B | ||
| -2.04% | -2.98% | +33.13% | +68.23% | 455B | ||
| +0.10% | -0.70% | +37.15% | +30.30% | 350B | ||
| -0.28% | -0.49% | +34.07% | +38.66% | 299B | ||
| -0.68% | -0.58% | +11.23% | +12.61% | 265B | ||
| -7.42% | -4.90% | -3.05% | -44.17% | 225B | ||
| -1.30% | +1.61% | +29.48% | +63.18% | 209B | ||
| -0.86% | +0.19% | +15.37% | +70.15% | 163B | ||
| Average | -1.45% | +4.09% | +24.14% | +47.47% | 361.28B | |
| Weighted average by Cap. | -1.53% | +4.87% | +37.72% | +70.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.13B 22.3M 19.37M 17.98M 16.59M 31.24M 31.81M 213M 83.36M 1.06B 83.73M 81.9M 3.56B | 6.2B 64.98M 56.44M 52.41M 48.34M 91.05M 92.7M 621M 243M 3.08B 244M 239M 10.36B |
| Net income | 215M 2.26M 1.96M 1.82M 1.68M 3.16M 3.22M 21.54M 8.43M 107M 8.47M 8.29M 360M | 291M 3.04M 2.64M 2.46M 2.27M 4.27M 4.34M 29.08M 11.38M 144M 11.43M 11.18M 486M |
| Net Debt | -178M -1.86M -1.62M -1.5M -1.39M -2.61M -2.66M -17.8M -6.97M -88.39M -7M -6.85M -297M | -42.9M -449K -390K -362K -334K -630K -641K -4.29M -1.68M -21.31M -1.69M -1.65M -71.65M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | ₹720.00 | +0.33% | 2,000 |
| 26-07-30 | ₹717.65 | -0.19% | 5,300 |
| 26-07-29 | ₹719.00 | +0.61% | 2,300 |
| 26-07-28 | ₹714.65 | -0.88% | 3,600 |
| 26-07-27 | ₹721.00 | +0.19% | 2,200 |
- Stock Market
- Stocks
- REMUS Stock
Select your edition
All financial news and data tailored to specific country editions
















